Xylem (XYL) Common Equity (2010 - 2026)

Xylem's Common Equity history runs 17 years deep, the most recent figure standing at $11.0 billion for Q1 2026.

• On a quarterly basis, Common Equity rose 1.39% year-over-year to $11.0 billion in Q1 2026; TTM through Mar 2026 was $11.0 billion, a 1.39% increase from a year earlier, with the FY2025 full-year figure at $11.5 billion, up 7.93% from the prior year.
• Common Equity fell to $11.0 billion in Q1 2026 per XYL's latest filing, from $11.5 billion in the prior quarter.
• Across five years, Common Equity topped out at $11.5 billion in Q4 2025 and bottomed at $3.2 billion in Q2 2022.
• The 5-year median for Common Equity is $10.2 billion (2024), against an average of $8.5 billion.
• Across the five-year window, Common Equity jumped 209.4% in 2023 and increased 1.39% in 2026, its largest moves.
• Year by year, Common Equity stood at $3.5 billion in 2022, then soared by 190.49% to $10.2 billion in 2023, then grew by 4.63% to $10.6 billion in 2024, then gained by 7.93% to $11.5 billion in 2025, then decreased by 4.52% to $11.0 billion in 2026.
• Per Business Quant, the three latest XYL Common Equity figures stand at $11.0 billion (Q1 2026), $11.5 billion (Q4 2025), and $11.2 billion (Q3 2025).